NIH, FDA Team Up To Develop Imaging Methodologies; NIBIB Puts In $400,000
This article was originally published in The Gray Sheet
Executive Summary
X-ray and computer-aided detection technologies are the first imaging device categories that NIH and FDA will evaluate for optimal performance under a recently inked interagency agreement
You may also be interested in...
McClellan’s FDA Legacy? Decisive Role In Product Development Priorities
FDA's "critical path" initiative to help streamline R&D costs and product development schedules is positioning the agency to eventually seek grant-making authority from Congress
McClellan’s FDA Legacy? Decisive Role In Product Development Priorities
FDA's "critical path" initiative to help streamline R&D costs and product development schedules is positioning the agency to eventually seek grant-making authority from Congress
R2 CAD Panel Conditions: Postmarket Clinical Efficacy Study, Data Reanalysis
A postmarket clinical efficacy study of R2 Technology's ImageChecker CT computer-aided detection (CAD) system for lung nodules should be a requirement for FDA approval, the agency's Radiological Devices Panel recommended Feb. 3